GENEVA—The use of combinations including checkpoint inhibition with other immunotherapies, other targeted therapies and chemotherapy was discussed at the European Lung Cancer Conference by Martin Reck MD PhD from the department of thoracic oncology at the Lung Clinic Grosshansdorf near Hamburg, Germany. He gave Oncology Times reporter Peter Goodwin his views about their potential impact on daily oncology practice.
Colorectal cancer screening: survey of 11 European countries finds big mortality benefit 6 Nov, 2013 
Targeting Emerging Drugable Pathways in Breast Cancer—Clinical Potential Assessed 28 Mar, 2015 
Higher Radiation Dose Improved Survival in Children with Ependymoma 12 May, 2015 
Low Cost Screening Could Halve Stillbirths Due To Syphilis 20 Jul, 2011 
COVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
Ultrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014